首页> 外文期刊>Journal of Diabetes and Metabolic Disorders >Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts
【24h】

Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts

机译:线粒体通透性过渡孔的抑制通过后处理恢复糖尿病心脏的心脏保护作用

获取原文
           

摘要

Background Cardiovascular risk factors, including diabetes mellitus may attenuate the cardioprotection by postconditioning. This study aimed to investigate the cardioprotective effect of ischemic-postconditioning (IPostC) against ischemia/reperfusion injury in normal and chronically type-1 diabetic rats and the effect of mitochondrial permeability transition pore (mPTP) inhibition in this field. Methods Diabetes was induced by a single intra-peritoneal injection of streptozotocin (50 mg/kg) in Wistar male rats (250-300 g). After 8 weeks, the hearts of control and diabetic animals were isolated and mounted on a constant-pressure Langendorff apparatus. All hearts were subjected to 30 min regional ischemia followed by 45 min reperfusion (by occluding and re-opening of LAD coronary artery, respectively). At the end of ischemia, the hearts received IPostC, cyclosporine-A, or both or none of them. Myocardial creatine-kinase (CK) release as an index of tissue injury was measured spectrophotometery in coronary effluent in reperfusion phase. Infarct size was identified by triphenyltetrazolium chloride staining. Heart rate, left ventricular end-diastolic pressure (LVEDP), LV systolic pressure (LVSP), rate-pressure product (RPP) and coronary flow were recorded throughout the experiment. Results IPostC, applied at the onset of reperfusion, failed to improve myocardial LVEDP and RPP, or reduce tissue damage indicated by infarct size and CK release in diabetic hearts, while it significantly recovered these parameters toward the pre-ischemic values in control hearts (P?
机译:背景技术包括糖尿病在内的心血管危险因素可能会因后处理而削弱心脏保护作用。这项研究旨在调查缺血后处理(IPostC)对正常和慢性1型糖尿病大鼠的缺血/再灌注损伤的心脏保护作用,以及在该领域抑制线粒体通透性转换孔(mPTP)的作用。方法腹腔注射链脲佐菌素(50 mg / kg)对Wistar雄性大鼠(250-300 g)进行单次糖尿病诱导。 8周后,将对照动物和糖尿病动物的心脏分离并固定在恒压Langendorff仪器上。所有心脏均经受30分钟的局部缺血,然后再灌注45分钟(分别通过闭塞和重新开放LAD冠状动脉)。缺血结束时,心脏接受了IPostC,环孢素A或两者均接受或均未接受。分光光度法在再灌注期测定冠状流出物中的心肌肌酸激酶(CK)释放作为组织损伤的指标。通过氯化三苯基四唑鎓染色鉴定梗塞大小。在整个实验中记录心率,左心室舒张末期压力(LVEDP),左室收缩压(LVSP),心率压积(RPP)和冠状动脉血流。结果IPostC于再灌注开始时未能改善心肌LVEDP和RPP或减少糖尿病性心肌梗死面积和CK释放所指示的组织损伤,但可将这些参数显着恢复至对照心脏的缺血前值(P <0.05。相反,在同时用环孢菌素A抑制mPTP的情况下,IPostC对糖尿病心脏的心肌血流动力学,梗死面积和CK释放的心脏保护作用得到了显着恢复(P <0.05)。结论通过联合应用iPostC和mPTP抑制作用来增强IPostC的保护效力,可以克服IPostC在糖尿病状态下对心脏的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号